$TEM

Tempus AI stock upgraded at Piper Sandler (TEM:NASDAQ)

Piper Sandler upgraded Tempus AI (TEM) to Overweight, raising its price target to $76 from $56. Analyst David Westenberg cited three key growth drivers for the AI-driven diagnostics company.

Original reporting
Published Sep 1, 2026, 3:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 4:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$TEM
Bullish
medium confidence
Mentioned
$TEM · $PIPR
Relevance
7/10
alphai data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$TEMBullishHigh
01

Why it matters

Analyst upgrade could attract new buying interest and lift the stock toward the new $76 target.

02

Market read

The upgrade adds a bullish catalyst for TEM, potentially influencing related AI‑health stocks.

03

What to watch

Execution risk of AI diagnostics rollout not detailed.

Relevance 7/10Novelty 7/10Timing: today

Background

Tempus AI is an AI‑driven diagnostics company listed on NASDAQ.

Company-level read

Ticker impact

$TEMBullishMedium confidence
Context

Piper Sandler upgraded Tempus AI to Overweight and raised its price target to $76 from $56.

Expected impact

Potential price increase toward new target.

Evidence & confidence

Upgrade and higher target reflect improved growth outlook.

Market effects

May boost sentiment for AI‑driven diagnostics sector.

Limited to US biotech/AI equities.

Minor global impact.

Counterpoint

Upgrade could be premature if growth drivers falter.

Key entities

  • Piper Sandler

    Provided the upgrade and new price target.

Related articles

High

Why is Tempus AI stock rallying today?

Tempus AI stock rose 2.7% in pre-market trading after Piper Sandler upgraded it to Overweight with a $76 price target, citing growth catalysts. Canaccord Genuity reiterated its Buy rating and $80 target, praising the company's Personalis acquisition. Tempus AI reported Q2 profitability and raised 2026 revenue guidance to $1.6B. The move contrasts with broader market declines.

$PIPRMedAI 8/10

A Look Back at Investment Banking & Brokerage Stocks’ Q2 Earnings: Piper Sandler (NYSE:PIPR) Vs The Rest Of The Pack

Investment banking & brokerage stocks reported Q2 earnings, with Piper Sandler (PIPR) revenues up 21.2% YoY, beating estimates. Perella Weinberg (PWP) revenues flat but beat estimates, while Houlihan Lokey (HLI) revenues down 15.6% YoY, missing estimates. LPL Financial (LPLA) revenues up 35.2% YoY, beating estimates. Stifel (SF) revenues up 13.2% YoY, beating estimates. Sector revenues beat consensus by 4.5%, with guidance 1.1% below.